Gastro-Cardiology: A Novel Perspective for the Gastrocardiac Syndrome

The gastrocardiac syndrome was coined originally at the beginning of the 19th century to describe an alleged gastric-cardiopathy with reflux heartburn mimicking cardiac chest pain. Today, a wider perspective of gastrocardiac syndrome has emerged. First, the cardiovascular risk factor chronic systemi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Robin Hofmann, Magnus Bäck
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/9720f0d2459d4798bff5e5c058fcef94
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9720f0d2459d4798bff5e5c058fcef94
record_format dspace
spelling oai:doaj.org-article:9720f0d2459d4798bff5e5c058fcef942021-11-17T07:01:46ZGastro-Cardiology: A Novel Perspective for the Gastrocardiac Syndrome2297-055X10.3389/fcvm.2021.764478https://doaj.org/article/9720f0d2459d4798bff5e5c058fcef942021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcvm.2021.764478/fullhttps://doaj.org/toc/2297-055XThe gastrocardiac syndrome was coined originally at the beginning of the 19th century to describe an alleged gastric-cardiopathy with reflux heartburn mimicking cardiac chest pain. Today, a wider perspective of gastrocardiac syndrome has emerged. First, the cardiovascular risk factor chronic systemic inflammation may reflect gastroenterological inflammatory conditions, such as inflammatory bowel disease and gastrointestinal infections, in particular, chronic Helicobacter pylori infection. Furthermore, since contemporary treatment of cardiovascular disease commonly includes potent antithrombotic medications, the cardiovascular benefit in terms of a decrease in the incidence of recurrent ischemic events and death needs to be carefully balanced with an increased risk of gastrointestinal bleeding. Several strategies to target chronic gastrointestinal inflammation and to diagnose and treat Helicobacter pylori to reduce the risk of cardiovascular events and gastrointestinal bleeding are available but residual controversy remains and large-scale gastro-cardiology trials are needed to determine the optimal treatment approaches. In perspective, the centennial gastrocardiac syndrome is more relevant than ever in a contemporary gastroenterology and cardiology setting. A collaborative subspecialty, namely Gastro-cardiology, would introduce novel unique means to study, diagnose and treat gastrocardiac conditions with the aim to reduce the risk of cardiovascular and bleeding events to improve the prognosis for gastro-cardiology patients.Robin HofmannMagnus BäckFrontiers Media S.A.articlegastrocardiac syndromeHelicobacter pyloricardiovascular diseaseupper gastrointestinal (GI) bleedingatherosclerosismortalityDiseases of the circulatory (Cardiovascular) systemRC666-701ENFrontiers in Cardiovascular Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic gastrocardiac syndrome
Helicobacter pylori
cardiovascular disease
upper gastrointestinal (GI) bleeding
atherosclerosis
mortality
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle gastrocardiac syndrome
Helicobacter pylori
cardiovascular disease
upper gastrointestinal (GI) bleeding
atherosclerosis
mortality
Diseases of the circulatory (Cardiovascular) system
RC666-701
Robin Hofmann
Magnus Bäck
Gastro-Cardiology: A Novel Perspective for the Gastrocardiac Syndrome
description The gastrocardiac syndrome was coined originally at the beginning of the 19th century to describe an alleged gastric-cardiopathy with reflux heartburn mimicking cardiac chest pain. Today, a wider perspective of gastrocardiac syndrome has emerged. First, the cardiovascular risk factor chronic systemic inflammation may reflect gastroenterological inflammatory conditions, such as inflammatory bowel disease and gastrointestinal infections, in particular, chronic Helicobacter pylori infection. Furthermore, since contemporary treatment of cardiovascular disease commonly includes potent antithrombotic medications, the cardiovascular benefit in terms of a decrease in the incidence of recurrent ischemic events and death needs to be carefully balanced with an increased risk of gastrointestinal bleeding. Several strategies to target chronic gastrointestinal inflammation and to diagnose and treat Helicobacter pylori to reduce the risk of cardiovascular events and gastrointestinal bleeding are available but residual controversy remains and large-scale gastro-cardiology trials are needed to determine the optimal treatment approaches. In perspective, the centennial gastrocardiac syndrome is more relevant than ever in a contemporary gastroenterology and cardiology setting. A collaborative subspecialty, namely Gastro-cardiology, would introduce novel unique means to study, diagnose and treat gastrocardiac conditions with the aim to reduce the risk of cardiovascular and bleeding events to improve the prognosis for gastro-cardiology patients.
format article
author Robin Hofmann
Magnus Bäck
author_facet Robin Hofmann
Magnus Bäck
author_sort Robin Hofmann
title Gastro-Cardiology: A Novel Perspective for the Gastrocardiac Syndrome
title_short Gastro-Cardiology: A Novel Perspective for the Gastrocardiac Syndrome
title_full Gastro-Cardiology: A Novel Perspective for the Gastrocardiac Syndrome
title_fullStr Gastro-Cardiology: A Novel Perspective for the Gastrocardiac Syndrome
title_full_unstemmed Gastro-Cardiology: A Novel Perspective for the Gastrocardiac Syndrome
title_sort gastro-cardiology: a novel perspective for the gastrocardiac syndrome
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/9720f0d2459d4798bff5e5c058fcef94
work_keys_str_mv AT robinhofmann gastrocardiologyanovelperspectiveforthegastrocardiacsyndrome
AT magnusback gastrocardiologyanovelperspectiveforthegastrocardiacsyndrome
_version_ 1718425875583598592